KK

Kiranmai Kakarlapudi Penmetsa

Director Nominee Director DIN 08520808
DIN 08520808 First appointment Jul 2019 Primary industry Chemicals
Unlock full profile Investments Β· shareholding Β· contact details
Past companies 1 historical roles
Total affiliations 1 Since Jul 2019
Shareholding value β€’β€’β€’β€’ Premium profile

About Kiranmai Kakarlapudi Penmetsa

Data last updated:

Kiranmai Kakarlapudi Penmetsa was a Nominee Director at Rasina Therapeuctics Private Limited (2019–2020). The company operates in Chemicals.

DIN 08520808
Primary Designation Nominee Director
Industry Chemicals
First Appointment 25 Jul 2019

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Rasina Therapeuctics Private Limited U24230TG2019PTC134362
Nominee Director25 Jul 20192019Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Rasina Therapeuctics Private Limited
Premium access

Shareholding and investment profile for Kiranmai Kakarlapudi Penmetsa

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Kiranmai Kakarlapudi Penmetsa

Kiranmai Kakarlapudi Penmetsa was first appointed on 25 Jul 2019 as Nominee Director at Rasina Therapeuctics Private Limited.

Kiranmai Kakarlapudi Penmetsa held 1 earlier board appointment: Rasina Therapeuctics Private Limited (Nominee Director, 25 Jul 2019 to 06 Nov 2020).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available